Impact of the 2023/24 autumn-winter COVID-19 seasonal booster campaign in preventing severe COVID-19 cases in Italy (October 2023–March 2024)

We assessed the impact of the 2023/2024 COVID-19 vaccination campaign in Italy by estimating the number of averted COVID-19 severe cases (i.e. COVID-19 associated hospitalisations or deaths) between October 2023 and March 2024, in those aged ≥60 years. We estimated that 565 (95 % CI: 497-625) cases, corresponding to 2.1 % (95 % CI: 1.8-2.3) of the expected cases without a vaccination campaign, were averted. We simulated three vaccination coverage scenarios: 50 %, 75 %, 90 % (versus the observed 10.7 %), finding that 9.7 % (95 % CI: 8.5-10.7); 14.5 % (95 % CI: 12.8-16.1); and 17.4 % (95 % CI: 15.3-19.3) of the expected cases would have been averted, respectively.

Authors

Institutions

Publication Details

Journal
Vaccine
Published
2024-09-19
DOI
https://doi.org/10.1016/j.vaccine.2024.126375
Citations
7
Primary Topic
Influenza Virus Research Studies
Type
article
Field-Weighted Citation Impact
2.71

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Impact of the 2023/24 autumn-winter COVID-19 seasonal booster campaign in preventing severe COVID-19 cases in Italy (October 2023–March 2024)

Emmanouil Alexandros Fotakis, Flavia Riccardo, Patrizio Pezzotti, Antonino Bella et al.
7 citations
Vaccine
Influenza Virus Research Studies
2.71
article

Impact of the 2023/24 autumn-winter COVID-19 seasonal booster campaign in preventing severe COVID-19 cases in Italy (October 2023–March 2024)

Emmanouil Alexandros Fotakis, Flavia Riccardo, Patrizio Pezzotti, Antonino Bella, Massimo Fabiani, Alberto Mateo‐Urdiales, Anna Odone, Chiara Sacco, Dario Petrone, Antonio Sciurti, Marco Tallon, Demetrio Cescutti, Martina Del Manso, Erica Picasso, L. de Angelis, Andrea Cannone
article en
7 citations

Abstract

We assessed the impact of the 2023/2024 COVID-19 vaccination campaign in Italy by estimating the number of averted COVID-19 severe cases (i.e. COVID-19 associated hospitalisations or deaths) between October 2023 and March 2024, in those aged ≥60 years. We estimated that 565 (95 % CI: 497-625) cases, corresponding to 2.1 % (95 % CI: 1.8-2.3) of the expected cases without a vaccination campaign, were averted. We simulated three vaccination coverage scenarios: 50 %, 75 %, 90 % (versus the observed 10.7 %), finding that 9.7 % (95 % CI: 8.5-10.7); 14.5 % (95 % CI: 12.8-16.1); and 17.4 % (95 % CI: 15.3-19.3) of the expected cases would have been averted, respectively.

VaccineVol. 42(26)
University of Pisa (IT), Vita-Salute San Raffaele University (IT), University of Pavia (IT), Istituto Superiore di Sanità (IT), European Centre for Disease Prevention and Control (SE)
European Commission, European Centre for Disease Prevention and Control
Climate action
Openalex Percentile: Top 9%
Influenza Virus Research Studies
2.71
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.